MINNEAPOLIS, Nov. 27,
2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:
TECH) today announced that Kim
Kelderman, President and Chief Executive Officer, will
present at the Citi 2024 Global Healthcare Conference on
Wednesday, December 4, 2024, at
3:15 p.m. EST. A live webcast of the
presentation can be accessed via the IR Calendar page of
Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH)
is a global life sciences company providing innovative tools and
bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With hundreds of
thousands of products in its portfolio, Bio-Techne generated
approximately $1.2 billion in net
sales in fiscal 2024 and has approximately 3,100 employees
worldwide. For more information on Bio-Techne and its brands,
please visit https://www.bio-techne.com or follow the
Company on social media
at: Facebook, LinkedIn, Twitter or YouTube.
|
Contact:
|
David Clair, Vice
President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-citi-2024-global-healthcare-conference-302316680.html
SOURCE Bio-Techne Corporation
